Apollo Hospitals Q2 FY27 Results: Revenue Rises 23% To ₹7,615 Crore And Consolidated Net Profit Grows 32% To ₹630 Crore

Apollo Hospitals Enterprise Limited reported consolidated revenue of ₹7,615 crore in Q2 FY27, registering growth of 23% year-on-year (YoY) compared with the corresponding quarter last year.

Consolidated profit after tax (PAT) increased 32% to ₹630 crore. The company's performance was supported by growth in hospital services, pharmacy operations and its digital healthcare platform, alongside in-hospital occupancy.

The Apollo Hospitals share price closed at ₹8,599.50 on 04 November, up 1.89% on the National Stock Exchange (NSE).

Apollo Hospitals Q2 Results: Financial Highlights

Consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) increased 29% to ₹1,191 crore, with an EBITDA margin of 16%. The figure included costs of ₹91 crore related to Apollo 24/7, including a non-cash employee stock option (ESOP) charge.

The Healthcare Services division remained a major contributor, with revenue increasing 23% to ₹3,900 crore. Its EBITDA grew 20% to ₹937 crore, with a margin of 24%.

Apollo Health and Lifestyle Limited (AHLL) reported revenue growth of 20% to ₹429 crore. EBITDA increased to ₹61 crore, while PAT stood at ₹26 crore compared with a loss in the year-ago quarter.

Apollo HealthCo recorded revenue of ₹3,286 crore, up 23% YoY. EBITDA increased to ₹193 crore, while PAT rose to ₹118 crore.

Apollo Hospitals Q2 FY27 Operational Performance

Hospital occupancy improved to 73% during the quarter, compared with 69% in Q2 FY26. Inpatient (IP) volumes in Healthcare Services increased 14%, while average revenue per patient (ARPP) rose 8% to ₹1,86,880.

International patient services revenue grew 37%, reflecting continued demand from overseas patients.

The company also reported growth across several clinical specialties, including Oncology, Gastroenterology, Cardiac, Orthopaedics and Urology. These areas contributed to higher patient volumes and a greater share of complex clinical work.

Apollo HealthCo added 222 net new pharmacy stores during the quarter, taking its total network to 7,662 stores. Its Apollo 24/7 platform recorded gross merchandise value (GMV) growth of 20%, while its core segment GMV increased 27% to ₹571 crore.

What Did Management Say?

Dr. Prathap C. Reddy, Founder and Chairman of Apollo Hospitals Group, said the quarterly performance was supported by higher volumes in complex specialties and contributions from hospitals across the network.

He also said the group's expansion programme was progressing, with newer hospitals being developed into dependable centres of care.

Source

NSE Archives

Also Read - Nykaa Q2 FY27 Results: Revenue Rises 28% To ₹3,006 Crore And Consolidated Net Profit Jumps 207% To ₹101 Crore